Recent Blog Posts

View Post: Two units of umbilical cord blood 'reduce leukemia recurrence risk ...
14 Nov 2009 by ANI  
Eighty-eight patients had acute lymphoblastic leukaemia (ALL) and 89 had acute myeloid leukaemia (AML). “Our analysis showed that patients in first or second remission from the leukaemia had a significantly lower likelihood of leukaemia ... from Trinity College Dublin (TCD) have discovered a new drug that can destroy cancerous cells in adult leukaemia patients who have developed resistance to other treatments.... New therapy shows promise in treating advanced leukemia ...
View Blog: Trak.in News» Trak.in News

---

View Post: Genentech, Biogen Idec get FDA request for more information on ...
18 Nov 2009 by AP  
The FDA did not ask for new data on the current application, which seeks approval as a treatment for chronic lymphocytic leukemia. It is the most common adult leukemia in the U.S.. Genentech and Biogen said they will continue final label discussions with the ... Doctors said the findings should change the standard of care for younger adults with acute myeloid leukemia, but work remains to find better treatment for the elderly, who are more likely to develop the disease. ...
View Blog: Health News - http://blog.taragana.com/health/

---

View Post: Blood -- Quantitative DNA-methylation predicts survival in adult ...
10 Nov 2009 by Bullinger, L., Ehrich, M., Dohner, K.,...  
Acute myeloid leukemia (AML) is characterized by molecular heterogeneity that is not fully reflected in the current classification system. Recent insights point towards a significant role of aberrant DNA-methylation in leukemogenesis. ...
View Blog: BLOOD First Edition Papers - http://bloodjournal.hematologylibrary.org/

---

View Post: Orphan drug designation granted to voreloxin for acute myeloid ...
5 Nov 2009
Sunesis Pharmaceuticals was granted orphan drug designation by the FDA for its drug candidate, voreloxin for the treatment of acute myeloid leukemia (AML). ... Elitek (rasburicase, from sanofi-aventis), a recombinant urate oxidase enzyme, has been approved for the initial management of plasma uric acid (PUA) levels in adult patients with leukemia, lymphoma, and solid tumor malignancies who are receiving anti-cancer therapy expected to result in tumor lysis syndrome (TLS) ...
View Blog: Latest articles from MPR - http://www.empr.com/

---

View Post: symptoms of acute myeloid leukemia - Health Resources - Health ...
9 Oct 2009 by Tiny  
Acute Myeloid Leukemia (Adult) - Symptoms, Treatment and Prevention . at diagnosis of acute myeloid leukemia is 65 . There are very few hereditary causes of acute myeloid leukemia. . Symptoms of Acute Myeloid Leukemia (Adult) . -> ...
View Blog: Health Resources - http://www.health-res.com/

---

View Post: U of M researchers find 2 units of umbilical cord blood reduce ...
13 Nov 2009 by BJS  
Eighty-eight patients had acute lymphoblastic leukemia (ALL) and 89 had acute myeloid leukemia (AML). "Our analysis showed that patients in first or second remission from the leukemia had a significantly lower likelihood of leukemia recurrence if they were ... "Given that adult patients were more likely to receive two UCB units and that they tend to have more aggressive leukemia, we think that the lower relapse rates with two UCB units is remarkable," says Verneris. ...
View Blog: Science Blog - Science news straight from... - http://www.scienceblog.com/cms/frontpage1

---

View Post: GlobalTort: Save a Life - Donate Cord Blood - New Science Shows ...
15 Nov 2009 by Kirk Hartley  
"Given that adult patients were more likely to receive two UCB units and that they tend to have more aggressive leukemia, we think that the lower relapse rates with two UCB units is remarkable," says Verneris. ... This analysis was performed to identify risk factors associated with leukemia relapse following myeloablative UCB transplantation. Acute leukemia patients (n 177; 88 with acute lymphoblastic leukemia and 89 with acute myeloid leukemia) were treated at a single ...
View Blog: GlobalTort - http://www.globaltort.com/

---

View Post: Sindh Today – Online News » Two units of umbilical cord blood ...
13 Nov 2009 by SindhToday  
Two units of umbilical cord blood 'reduce leukemia recurrence risk'. November 13th, 2009 SindhToday. Washington, Nov 14 (ANI): If patients with acute leukaemia are transplanted with two units of umbilical cord blood (UCB), their risk of the disease recurrence ... 'Given that adult patients were more likely to receive two UCB units and that they tend to have more aggressive leukaemia, we think that the lower relapse rates with two UCB units is remarkable,' said Verneris. ...
View Blog: Sindh Today - Online News - http://www.sindhtoday.net/

---

View Post: Targeted treatment of acute myeloid leukemia in older adults: role of
9 Nov 2009
Abstract: As the overall prognosis and treatment response rate to standard chemotherapy for acute myeloid leukemia (AML) remains poor in the older adult population, there is a need for more effective therapeutic agents with lower ...
View Blog: Clinical Interventions in Aging - http://www.dovepress.com/clinical-interventions-in-aging-journal

---

View Post: Stem Cell: Leukemia - Table of Contents alert Volume 23 Issue 11
11 Nov 2009 by Manoj Kumar Valluru  
Novel epigenetic mechanisms that control pluripotency and quiescence of adult bone marrow-derived Oct4+ very small embryonic-like stem cells D M Shin, E K Zuba-Surma, W Wu, J Ratajczak, M Wysoczynski, M Z Ratajczak and M Kucia ... A robust xenotransplantation model for acute myeloid leukemia P V Sanchez, R L Perry, J E Sarry, A E Perl, K Murphy, C R Swider, A Bagg, J K Choi, J A Biegel, G Danet-Desnoyers and M Carroll ...
View Blog: Stem Cell - http://stemcellbiology.blogspot.com/

---